Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:1198-1205
Published online before print November 17, 2003, doi: 10.1161/01.HYP.0000103162.76220.51
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/6/1198    most recent
01.HYP.0000103162.76220.51v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J.-C.
Right arrow Articles by Cheng, T.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.-C.
Right arrow Articles by Cheng, T.-H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antioxidants
Related Collections
Right arrow Cardiovascular Pharmacology

(Hypertension. 2003;42:1198.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Inhibition of Cyclic Strain-Induced Endothelin-1 Gene Expression by Resveratrol

Ju-Chi Liu; Jin-Jer Chen; Paul Chan; Ching-Feng Cheng; Tzu-Hurng Cheng

From the Department of Medicine, Taipei Medical University, Wan Fang Hospital (J.-C.L., P.C., T.-H.C.), Taipei; the Institute of Biomedical Sciences, Academia Sinica (J.-J.C, C.-F.C., T.-H.C.), Taipei; the Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine (J.-J.C.), Taipei; and the Department of Pharmacology, National Defense Medical Center (T.-H.C.), Taipei, Taiwan, Republic of China.

Correspondence to Tzu-Hurng Cheng, PhD, Division of Cardiology, Department of Medicine, Taipei Medical University-Wan Fang Hospital, No. 111, Hsing Lung Road, Section 3, Wen-Shan District, Taipei 117, Taiwan. E-mail thcheng{at}gate.sinica.edu.tw

Resveratrol is a phytoestrogen naturally found in grapes and is among the major constituents of wine thought to have a cardioprotective effect. Endothelin-1 (ET-1) is a potent vasopressor synthesized by endothelial cells both in culture and in vivo. The aims of this study were to test the hypothesis that resveratrol may alter strain-induced ET-1 gene expression and to identify the putative underlying signaling pathways in endothelial cells. We show that resveratrol indeed potently inhibits strain-induced ET-1 secretion, ET-1 mRNA level, and ET-1 promoter activity. Resveratrol also inhibits strain-increased NADPH oxidase activity, reactive oxygen species formation, and extracellular signal–regulated kinases1/2 (ERK1/2) phosphorylation. Furthermore, pretreating cells with resveratrol or antioxidant N-acetyl-cysteine decreases strain-increased or hydrogen peroxide–increased ET-1 secretion, ET-1 promoter activity, and ET-1 mRNA and ERK1/2 phosphorylation. Using both the electrophoretic mobility shift assay and a reporter gene assay, resveratrol and N-acetyl-cysteine also attenuated the strain-stimulated activator protein-1 binding activity and activator protein-1 reporter activity. In summary, we demonstrate for the first time that resveratrol inhibits strain-induced ET-1 gene expression, partially by interfering with the ERK1/2 pathway through attenuation of reactive oxygen species formation. Thus, this study provides important new insights in the molecular pathways that may contribute to the proposed beneficial effects of resveratrol in the cardiovascular system.


Key Words: endothelin • gene expression • atherosclerosis • endothelium • oxygen • kinase




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Lekli, G. Szabo, B. Juhasz, S. Das, M. Das, E. Varga, L. Szendrei, R. Gesztelyi, J. Varadi, I. Bak, et al.
Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H859 - H866.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S.-H. Juan, J.-J. Chen, C.-H. Chen, H. Lin, C.-F. Cheng, J.-C. Liu, M.-H. Hsieh, Y.-L. Chen, H.-H. Chao, T.-H. Chen, et al.
17{beta}-Estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1254 - H1261.
[Abstract] [Full Text] [PDF]